Tag Archives: AllianceRx

Walgreens Looking To Make a Significant Impact in Specialty Pharmacy Market

Walgreens plans to expand its specialty pharmacy services and invest in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners.

Mycovia Pharmaceuticals Selects AllianceRx as Exclusive Pharmacy For VIVJOA

AllianceRx Walgreens announced that Walgreens specialty pharmacy patients will now have exclusive access to VIVJOA®, through AllianceRx Walgreens Pharmacy, a subsidiary of Walgreens

Specialty Pharmacy News Roundup: December 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Specialty Pharmacy News Roundup: May 2023

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

AllianceRx Walgreens Prime Rebranding as AllianceRx Walgreens Pharmacy

AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease

AllianceRx Walgreens Prime Expanding Digital Clinical Capabilities with Highmark

AllianceRx Walgreens Prime’s digital clinical assessments are available for patients with chronic inflammatory disease, multiple sclerosis, cystic fibrosis, idiopathic pulmonary fibrosis, organ transplants, lipid and blood disorders